antivir
potenti
small
interf
rna
sirna
target
rabi
viru
rv
polymeras
l
nucleoprotein
n
gene
deliv
lentivir
vector
investig
vitro
evalu
sirna
express
cell
line
bhkl
bhkn
develop
use
transduct
lentil
lentin
lentivirus
encod
sirna
rvl
n
gene
respect
cell
line
challeng
vitro
rv
pasteur
strain
reduct
number
rvspecif
foci
target
gene
transcript
indic
inhibitori
effect
rv
multipl
vivo
evalu
mice
treat
intracerebr
lentivirus
challeng
ld
rv
challeng
viru
strain
intramuscular
rout
masset
muscl
five
eight
mice
treat
lentin
surviv
indic
protect
control
lentiltr
mice
die
within
day
indic
lethal
natur
challeng
viru
protect
result
demonstr
sirna
target
rvn
could
inhibit
rv
multipl
also
confer
protect
mice
lethal
rv
challeng
find
implic
therapeut
use
sirna
target
rvn
rv
infect
one
strike
featur
rnai
perform
sequencespecif
degrad
perfectli
complimentari
rna
mediat
small
interf
rna
sirna
led
develop
new
therapeut
target
viralassoci
rna
without
affect
host
cellular
rna
anim
well
human
pathogen
virus
except
target
rnai
exogen
uniqu
natur
sequenc
host
minim
offtarget
side
effect
specif
inhibit
essenti
viral
gene
prevent
viral
multipl
mammalian
cell
trigger
introduct
synthet
doublestrand
sirna
altern
transcript
sirna
dna
construct
driven
rna
polymeras
express
cassett
rnaibas
antivir
approach
investig
sever
virus
review
includ
human
immunodefici
viru
hepat
b
viru
dengu
viru
human
papilloma
viru
polioviru
hepat
c
viru
respiratori
syncyti
viru
sever
acut
respiratori
syndrom
coronaviru
influenza
viru
addit
sever
report
investig
potenti
rnai
rabi
infect
rabi
viru
rv
rna
viru
belong
genu
lyssaviru
famili
rhabdovirida
viru
highli
neurotrop
usual
transmit
one
infect
anim
anoth
anim
human
bite
viru
enter
nervou
system
new
host
nerv
end
near
bite
site
rv
establish
viremia
infect
host
howev
viral
pathogenesi
target
brain
use
peripher
nerv
neuron
central
nervou
system
cn
viru
replic
transport
natur
condit
rv
infect
cn
caus
rel
mild
neuropatholog
chang
without
promin
evid
neuron
death
observ
led
concept
neurolog
symptom
rabi
result
neuron
dysfunct
rather
neuron
cell
death
promis
power
rnai
select
elimin
target
rna
cell
without
disturb
cellular
function
cytopatholog
chang
strategi
develop
inhibit
rv
multipl
cn
block
pathogen
process
therefor
diseas
progress
may
prevent
among
five
rv
protein
nucleoprotein
n
phosphoprotein
p
polymeras
l
protein
import
target
rnai
owe
role
viral
transcript
replic
report
vitro
evalu
rnai
rabi
target
viral
structur
gene
like
n
glycoprotein
g
also
remain
potenti
target
rnai
rvg
consid
essenti
viru
transsynapt
spread
neuron
vivo
target
rnai
rabi
nonstructur
gene
like
matrix
phosphoprotein
p
limit
antivir
potenti
previou
vitro
studi
indic
short
rvn
cdna
artifici
microrna
could
interfer
rv
replic
synthet
sirna
rvn
could
reduc
rv
multipl
cell
group
also
evalu
sirna
target
rvl
n
gene
antivir
potenti
deliv
use
adenovir
vector
vitro
cell
vivo
mice
inhibit
rv
multipl
moder
level
protect
lethal
rv
challeng
studi
lentiviralbas
sirna
deliveri
system
use
deliv
sirna
shrna
mean
promot
target
rvl
n
gene
analyz
antivir
effect
vitro
cell
vivo
mice
lethal
rv
challeng
babi
hamster
human
embryon
cell
grown
co
dulbecco
modifi
minimum
essenti
medium
dmem
hyclon
supplement
fetal
bovin
serum
fb
hyclon
gl
sodium
bicarbon
mm
hepe
hyclon
nonessenti
amino
acid
neaa
hyclon
mgl
amphotericin
b
hyclon
mgl
gentamicin
sigma
rv
pasteur
strain
adapt
use
vitro
challeng
studi
cell
mous
brainadapt
rv
challeng
viru
strain
use
vivo
challeng
mice
swiss
albino
mice
week
old
either
sex
use
vivo
experi
accord
guidelin
given
committe
purpos
control
supervis
experi
anim
cpcsea
ministri
environ
forest
govern
india
rvl
n
target
genecarri
plasmid
pdsredl
pdsredn
respect
construct
express
fusion
rvl
n
protein
red
fluoresc
protein
rfp
ctermin
end
portion
rvl
gene
bp
contain
sirna
target
site
amplifi
rtpcr
revers
transcript
pcr
rabrfplf
rabrfplr
primer
tabl
rv
clone
vector
clontech
similarli
pdsredn
construct
amplifi
fulllength
bp
rvn
gene
rtpcr
use
rabrfpnf
rabrfpnr
primer
tabl
clone
vector
express
rfp
fusion
protein
nrfp
lrfp
confirm
transfect
cell
sens
antisens
oligonucleotid
tabl
sens
antisens
sirna
loop
sequenc
anneal
clone
pmcsgfp
plasmid
recombin
plasmid
design
shlpmcsgfp
shnpmcsgfp
sirna
sil
sin
express
shrna
use
promot
pmcsgfp
contain
enhanc
green
fluoresc
protein
gfp
report
gene
cell
cotransfect
target
gene
report
plasmid
pdsredl
pdsredn
express
rvl
n
protein
ctermin
rfp
fusion
lrfp
nrfp
sirna
express
plasmid
shlpmcsgfp
shnpmcsgfp
controlscrambl
sirna
express
plasmid
shcpmcsgfp
use
lipofectamin
reagent
invitrogen
plate
accord
manufactur
instruct
h
posttransfect
cell
analyz
rfp
gfp
express
use
olympu
fluoresc
microscop
produc
replicationdefici
lentivirus
encod
differ
sirna
lentivirus
produc
calcium
phosphatemedi
plasmid
cotransfect
cell
per
method
describ
earlier
brief
cell
confluent
cell
cm
flask
cotransfect
differ
recombin
pmcsgfp
either
shlpmcsgfp
shnpmcsgfp
control
along
helper
plasmid
viru
supernat
collect
day
posttransfect
concentr
use
ultracentrifug
h
pellet
resuspend
hbss
titrat
lentiviru
sil
sin
sequenc
design
lentil
lentin
respect
determin
transduct
unit
tu
titer
cell
cell
plate
transduc
differ
tenfold
dilut
lentiviru
stock
tu
titer
determin
base
gfp
express
cell
count
per
method
describ
earlier
cell
transduc
differ
lentivirus
lentil
lentin
multipl
infect
moi
presenc
polybren
lgml
sinc
lentiviru
backbon
contain
enhanc
green
fluoresc
protein
gfp
report
gene
express
indic
transduct
sirna
express
cassett
genom
cell
gfp
express
transduc
cell
sort
three
time
fluoresc
activ
cell
sorter
fac
get
maximum
percentag
gfpexpress
transduc
cell
lentil
lentin
transduc
homogen
cell
design
bhkl
bhkn
respect
verifi
sequenc
integr
sirna
express
cassett
bhkl
bhkn
cell
genom
dna
cell
isol
per
method
describ
earlier
fragment
contain
sirna
express
cassett
amplifi
pcr
use
retro
retro
primer
tabl
nucleotid
sequenc
determin
sirna
express
cell
line
bhkl
bhkn
transfect
target
gene
express
plasmid
pdsredl
pdsredn
plate
use
lipofectamin
reagent
invitrogen
h
posttransfect
transfect
cell
analyz
reduct
lrfp
nrfp
express
compar
transfect
control
cell
nuclear
counter
stain
dapi
quantit
realtim
pcr
qpcr
quantit
determin
rvl
n
transcript
qpcr
use
brief
bhkl
bhkn
cell
plate
infect
rv
moi
h
total
rna
isol
use
trizol
ls
reagent
invitrogen
accord
manufactur
instruct
cdna
prepar
oligo
dt
primer
use
mmulvrt
fermenta
accord
manufactur
protocol
rvl
n
gene
transcript
dilut
cdna
quantifi
use
genespecif
realtim
primer
tabl
use
kapa
sybr
fast
qpcr
kit
kapa
biosystem
accord
manufactur
instruct
rel
quantif
gapdh
gene
transcript
use
refer
normal
percent
reduct
level
target
mrna
transcript
determin
per
method
describ
earlier
challeng
sirna
treat
mice
rv
two
group
mice
n
treat
intracerebr
inject
lentil
lentin
lentiviru
particl
four
differ
site
one
group
mice
n
inject
hbss
kept
neg
control
seven
day
inject
lentiviru
mice
group
challeng
intramuscular
rout
masset
muscl
ld
virul
rv
strain
accord
nih
test
potenc
mice
maintain
normal
condit
observ
day
death
anim
rabiesspecif
symptom
record
event
particular
day
percent
surviv
calcul
rv
titer
level
gene
transcript
compar
statist
analysi
use
oneway
anova
follow
tukey
test
treatment
versu
control
differ
group
p
b
consid
statist
signific
data
present
mean
sem
comparison
surviv
group
done
logrank
test
accord
mantelhaenszel
method
use
graphpad
prism
version
graphpad
sil
target
rvl
mrna
nucleotid
posit
nt
sin
target
rvn
mrna
nt
clone
pmcsgfp
shrna
express
util
rna
pol
iii
promot
plasmid
cotransfect
experi
cell
rfp
indic
express
rfptag
version
rvl
n
protein
lrfp
nrfp
cell
gfp
express
indic
presenc
sirna
express
plasmid
fig
cell
transfect
target
gene
report
plasmid
sirna
express
plasmid
indic
reduct
rfp
express
indic
reduct
fusion
transcript
rv
target
gene
rfp
comparison
control
cotransfect
neg
control
sirna
express
plasmid
fig
confirm
express
sirna
effect
silenc
rv
target
gene
sequencespecif
manner
differ
lentivirus
name
lentil
lentin
mean
tu
titer
tuml
tuml
respect
prepar
plasmid
cotransfect
method
cell
cell
line
bhkl
bhkn
express
sirna
sil
sin
construct
transduct
use
differ
lentivirus
lentil
lentin
sort
bhkl
bhkn
cell
line
indic
gfp
express
cell
respect
indic
homogen
natur
sirna
express
cell
line
fig
sirna
express
cassett
cell
line
found
correct
nucleotid
sequenc
data
shown
evalu
sirna
knockdown
target
rv
gene
transcript
bhkl
bhkn
cell
transfect
target
gene
express
plasmid
pdsredl
pdsredn
fig
sirna
express
cell
infect
rv
mark
reduct
rvspecif
foci
bhkl
bhkn
cell
compar
control
cell
fig
indic
inhibitori
effect
sirna
rv
multipl
estim
target
genespecif
effect
sirna
precis
abil
knockdown
rv
gene
transcript
analyz
quantit
use
qpcr
level
rvl
n
gene
transcript
bhkl
cell
reduc
respect
compar
level
rvinfect
cell
fig
similarli
level
rvl
n
gene
transcript
bhkn
cell
also
reduc
respect
fig
evalu
inhibitori
effect
sirna
rv
multipl
quantit
determin
progeni
rv
releas
sirna
express
infect
cell
analyz
rvinfect
cell
cultur
supernat
bhkl
bhkn
show
ffu
ml
rv
titer
respect
control
cell
supernat
show
ffuml
rv
fig
indic
reduct
rv
titer
bhkl
bhkn
respect
compar
control
cell
result
averag
four
independ
experi
indic
sirna
name
sil
sin
express
cell
use
analyz
effect
lentiviraldeliv
sirna
inhibit
rv
multipl
vivo
lentivirustr
mice
challeng
rv
challeng
viru
strain
accord
nih
method
determin
potenc
control
mice
develop
rabiesspecif
symptom
die
within
day
postchalleng
median
surviv
day
protect
mice
treat
lentil
howev
median
surviv
day
increas
day
compar
control
mice
treatment
mice
lentin
lentiviru
express
sirna
rvn
demonstr
protect
fig
mice
surviv
day
develop
symptom
rabi
remain
healthi
till
entir
period
observ
month
result
indic
treatment
mice
lentiviru
express
sirna
rvn
confer
modest
protect
lethal
rv
challeng
replic
cycl
negativesens
rna
virus
includ
rv
consist
two
success
event
name
transcript
viral
gene
produc
viral
protein
follow
replic
viru
genom
use
virusencod
polymeras
l
protein
among
five
viral
protein
nucleoprotein
n
import
role
format
ribonucleoproteinrna
complex
requir
templat
transcript
observ
level
rvn
protein
crucial
switch
transcript
replic
viru
life
cycl
therefor
studi
rvl
n
gene
target
rnai
approach
evalu
effect
rv
multipl
previou
studi
includ
evalu
effect
sirna
target
differ
rv
gene
rv
multipl
vitro
cell
vivo
mice
inhibitori
effect
sirna
rvn
found
effici
interf
express
viral
gene
confer
moder
protect
lethal
rv
challeng
mice
treat
intracerebr
adenovirusexpress
sirna
present
studi
select
lentivir
system
sirna
deliveri
advantag
sirna
deliveri
method
name
longterm
continu
silenc
target
gene
deliveri
wide
rang
cell
includ
divid
nondivid
cell
eg
neuron
apart
lentivir
vector
less
immunogen
make
prefer
vector
system
vivo
deliveri
characterist
lentivir
vector
make
suitabl
sirna
deliveri
nerv
cell
target
cell
rv
infect
evalu
lentiviralbas
deliveri
sirna
present
studi
sirna
deliv
cell
evalu
inhibit
rv
multipl
use
differ
approach
like
reduct
rvspecif
foci
sirna
express
cell
inhibit
viru
multipl
knockdown
rv
target
gene
transcript
reduct
productionreleas
infect
rv
sirna
express
cell
reduct
number
rvinfect
foci
sirna
express
cell
compar
control
cell
indic
inhibit
rv
multipl
inhibit
quantifi
level
rv
gene
transcript
qpcr
sinc
rnai
function
identifi
degrad
mrna
share
sequenc
complementari
sirna
qpcr
analysi
use
analyz
effect
sirna
rvn
l
mrna
express
level
rvl
n
mrna
sirna
express
rvinfect
cell
significantli
reduc
compar
control
cell
howev
sil
less
effici
transcript
reduct
assay
fig
corrobor
observ
sirna
n
nipah
viru
effect
sirna
l
suggest
transcript
quantiti
might
also
play
role
sirna
efficaci
rvinfect
cell
among
rv
transcript
rvn
transcript
abund
l
transcript
least
abund
apart
transcript
reduct
assay
sirna
sil
sin
equal
effect
reduc
rv
target
gene
express
fig
rvspecif
foci
fig
progeni
rv
releas
sirna
express
cell
fig
sinc
rvn
l
protein
interrel
effect
viru
multipl
sirna
target
rvl
n
gene
exhibit
nonsignific
differ
inhibit
rv
multipl
next
step
sirna
express
lentivirus
analyz
inhibit
rv
multipl
vivo
mice
virul
rv
challeng
lentiltr
mice
show
delay
death
compar
control
mice
lentiltr
mice
die
day
postchalleng
median
surviv
day
lentintr
mice
show
protect
indic
knockdown
rvl
gene
sirna
could
prolong
outcom
infect
contrast
knockdown
rvn
gene
sirna
could
prolong
outcom
diseas
also
confer
protect
less
effect
knockdown
rvl
gene
mice
protect
might
due
limit
role
pathogenesi
encod
nonstructur
rnadepend
rna
polymeras
protein
viru
genom
replic
howev
signific
protect
mice
treat
sin
might
attribut
dual
role
rvn
protein
viral
structur
regulatori
protein
rv
pathogenesi
result
previou
studi
show
synthet
sirna
artifici
microrna
mirna
rvn
could
reduc
rv
titer
cell
studi
support
rvn
mrna
could
good
target
intervent
inhibit
rv
replic
previou
studi
use
adenovir
deliveri
sirna
target
rvl
n
gene
demonstr
low
moder
level
protect
respect
mice
treat
adenovirus
express
sirna
studi
use
lentivir
deliveri
sirna
target
rvl
inhibit
rv
multipl
vitro
cell
protect
mice
lethal
rv
challeng
howev
sirna
target
rvn
could
inhibit
rv
multipl
vitro
cell
also
demonstr
consist
moder
level
protect
treat
mice
lethal
rv
challeng
report
indic
signific
implic
use
viral
vectorbas
sirna
deliveri
antivir
approach
rv
infect
potenti
sirna
target
rvn
therapeut
use
rv
infect
explor
care
optim
dose
time
therapeut
administr
either
alon
combin
sirna
target
rv
gene
